Target intelligence / Profile preview

Microbial nucleic acids and nucleotides

Molecular classification
Nucleic acid, DNA, RNA
01

Overview

Microbial nucleotides and nucleic acids encompass the DNA and RNA molecules that serve as the fundamental genetic material for pathogens, including bacteria, viruses, fungi, and parasites. These molecules are essential for the storage of genetic blueprints and the execution of biological processes such as replication, transcription, and translation, which are required for microbial survival and proliferation (StatPearls, 2023). In pharmacology, they are critical targets for a wide range of antimicrobial agents that exploit structural or enzymatic differences between microbial and host genetic machinery. Some drugs act by directly damaging the nucleic acid structure, such as nitroimidazoles that cause DNA strand breakage, while others are nucleoside or nucleotide analogs that incorporate into growing chains to cause premature termination (NIH, 2022; PubChem, 2024). While these targets provide a basis for selective toxicity, challenges such as the rapid development of resistance through genetic mutations and potential off-target effects on host mitochondrial DNA remain significant considerations in drug development (PubMed, 2021).

Other names
Pathogen DNA and RNAMicrobial genetic materialBacterial DNAViral RNAMicrobial genomePathogen nucleic acids
02

Mechanism of action

Drugs targeting microbial nucleic acids primarily act through direct chemical damage (e.g., strand breakage), intercalation between base pairs to disrupt replication and transcription, or by acting as nucleoside/nucleotide analogs that cause premature chain termination during synthesis (StatPearls, 2023; PubChem, 2024).

03

Biological functions

Genetic information storageReplicationTranscriptionTranslation
04

Disease associations

InfectionBacterial infectionViral infectionFungal infectionParasitic infection
05

Safety considerations

Mutagenicity in host cellsMitochondrial toxicityBone marrow suppressionTeratogenicityRapid emergence of microbial resistance
06

Interacting drugs

Metronidazole

9 more in the full profile.

07

Biomarkers

Viral load (quantified via PCR)Bacterial DNA/RNA detectionGenetic mutations associated with drug resistance

Beyond the preview

Go deeper on Microbial nucleic acids and nucleotides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial nucleic acids and nucleotides.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call